Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
To evaluate the diagnostic accuracy of positron emission mammography (PEM) for identifying malignant lesions in patients with suspicious microcalcifications detected on mammography.
A prospective, single-centre study that evaluated 40 patients with suspicious calcifications at mammography and indication for percutaneous or surgical biopsy, with mean age of 56.4 years (range: 28-81 years). Patients who agreed to participate in the study underwent PEM with 18F-fluorodeoxyglucose before the final histological evaluation. PEM findings were compared with mammography and histological findings.
Most calcifications (n = 34; 85.0 %) were classified as BIRADS 4. On histology, there were 25 (62.5 %) benign and 15 (37.5 %) malignant lesions, including 11 (27.5 %) ductal carcinoma in situ (DCIS) and 4 (10 %) invasive carcinomas. On subjective analysis, PEM was positive in 15 cases (37.5 %) and most of these cases (n = 14; 93.3 %) were confirmed as malignant on histology. There was one false-positive result, which corresponded to a fibroadenoma, and one false negative, which corresponded to an intermediate-grade DCIS. PEM had a sensitivity of 93.3 %, specificity of 96.0 % and accuracy of 95 %.
PEM was able to identify all invasive carcinomas and high-grade DCIS (nuclear grade 3) in the presented sample, suggesting that this method may be useful for further evaluation of patients with suspected microcalcifications.
• Many patients with suspicious microcalcifications at mammography have benign results at biopsy.
• PEM may help to identify invasive carcinomas and high-grade DCIS.
• Management of patients with suspicious calcifications can be improved.
KeywordsBreast neoplasms Carcinoma ductal in situ Mammography Fluorodeoxyglucose F18 Positron emission tomography
- 95 % CI
95 % confidence interval
area under the curve
Breast Imaging Report and Data System
ductal carcinoma in situ
lesion to background
negative predictive value
Positron emission mammography
Positron emission tomography/computed tomography
positive predictive value
PEM uptake value
- 1.Siu AL (2016) Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 151:716–726Google Scholar
- 14.Glass SB, Shah ZA (2013) Clinical utility of positron emission mammography. Proc (Bayl Univ Med Cent) 26:314–319Google Scholar
- 20.Sickles EA, D’Orsi CJ, Bassett LW et al (2013) ACR BI-RADS Mammography. In: ACR BI-RADS Atlas, breast imaging reporting and data system. American College of Radiology, Reston, VAGoogle Scholar